Chronic perfusion of angiotensin II causes cognitive dysfunctions and anxiety in mice

Physiology and Behavior

Volumn 109, Issue 1, 2013, Pages 63-68

  Duchemin, S ^a   Belanger, E ^a   Wu, R ^a   Ferland, G ^a   Girouard, H ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Angiotensin II; Anxiety; Hypertension; Learning; Memory

Indexed keywords

ANGIOTENSIN II; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANXIETY; ANXIETY DISORDER; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BRAIN PERFUSION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; ELEVATED PLUS MAZE TEST; HYPERTENSION; LEARNING; MAZE TEST; MEMORY; MINIPUMP; MORRIS WATER MAZE TEST; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; VISUAL ACUITY;

EID: 84871819436     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2012.10.005     Document Type: Article

References (37)

1. Pereira M., Lunet N., Azevedo A., Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens 2009, 27(5):963-975.
2. Ciobica A., Padurariu M., Bild W., Stefanescu C. Cardiovascular risk factors as potential markers for mild cognitive impairment and Alzheimer's disease. Psychiatr Danub 2011, 23(4):340-346.
3. Israeli-Korn S.D., Masarwa M., Schechtman E., Abuful A., Strugatsky R., Avni S., et al. Hypertension increases the probability of Alzheimer's disease and of mild cognitive impairment in an Arab community in northern Israel. Neuroepidemiology 2010, 34(2):99-105.
4. Razay G., Williams J., King E., Smith A.D., Wilcock G. Blood pressure, dementia and Alzheimer's disease: the OPTIMA longitudinal study. Dement Geriatr Cogn Disord 2009, 28(1):70-74.
5. Kuusisto J., Koivisto K., Mykkanen L., Helkala E.L., Vanhanen M., Hanninen T., et al. Essential hypertension and cognitive function: the role of hyperinsulinemia. Hypertension 1993, 22:771-779.
6. Rountree S.D., Waring S.C., Chan W.C., Lupo P.J., Darby E.J., Doody R.S. Importance of subtle amnestic and nonamnestic deficits in mild cognitive impairment: prognosis and conversion to dementia. Dement Geriatr Cogn Disord 2007, 24(6):476-482.
7. The ONTARGET Investigators Telmisartan, ramipril, or both in patients at high risk for vascular events. N Eng J Med 2008, 358(15):1547-1559.
8. The Telmisartan Randomised Assessment Study in ACE intolerant subjects with cardiovascular Disease (TRANSCEND) Investigators Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet 2008, 372(9644):1174-1183.
9. Diener H.C., Sacco R.L., Yusuf S. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the prevention regimen for effectively avoiding second strokes (PROFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol 2008, 7(10):875-884.
10. Fogari R., Mugellini A., Zoppi A. Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients. J Hum Hypertens 2006, 20(3):177-185.
11. Li N.C., Lee A., Whitmer R.A., et al. Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. Br Med J 2010, 340:b5465.
12. Cheung B.M., Au T., Chan S., Lam C., Lau Sh., Lee R., et al. The relationship between hypertension and anxiety or depression in Hong Kong Chinese. Exp Clin Cardiol 2005, 10(1):21-24.
13. McLaughlin T., Geissler E.C., Wan G.J. Comorbidities and associated treatment charges in patients with anxiety disorders. Pharmacotherapy 2003, 23(10):1251-1256.
14. Yilmaz S., Pekdemir M., Tural U., Uygun M. Comparison of alprazolam versus captopril in high blood pressure: a randomized controlled trial. Blood Pressure 2011, 20(4):239-243.
15. Grossman E., Nadler M., Sharabi Y., Thaler M., Shachar A., Shamiss A. Antianxiety treatment in patients with excessive hypertension. Am J Hypertens 2005, 18(9 Pt 1):1174-1177.
16. 1 receptor antagonists are anti-stress compounds in vivo. Acad Sci 2008, 1148:360-366.
17. Tota S., Kamat P.K., Awasthi H., Singh N., Raghubir R., Nath C., et al. Candesartan improves memory decline in mice: involvement of AT1 receptors in memory deficit induced by intracerebral streptozotocin. Behav Brain Res 2009, 199(2):235-240.
18. Georgiev V., Yonkov D. Participation of angiotensin II in learning and memory. I. Interaction of angiotensin II with saralasin. Methods Find Exp Clin Pharmacol 1985, 7(8):415-418.
19. Kerr D.S., Bevilaqua L.R., Bonini J.S., Rossato J.I., Köhler C.A., Medina J.H., et al. Angiotensin II blocks memory consolidation through an AT2 receptor-dependent mechanism. Psychopharmacology (Berl) 2005, 179(3):529-535.
20. Inaba S., Iwai M., Furuno M., Tomono Y., Kanno H., Senba I., et al. Continuous activation of renin-angiotensin system impairs cognitive function in renin/angiotensinogen transgenic mice. Hypertension 2009, 53(2):356-362.
21. Kazama K., Anrather J., Zhou P., Girouard H., Frys K., Milner T.A., et al. Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circ Res 2004, 95(10):1019-1026. [12].
22. D'Hooge R., De Deyn Peter P. Applications of the Morris water maze in the study of learning and memory. Brain Res Rev 2001, 36:60-90.
23. Picard P., Chretien L., Couture R. Functional interaction between losartan and central tachykinin NK3 receptors in the conscious rat. Br J Pharmacol 1995, 114(8):1563-1570.
24. Capone C., Faraco G., Peterson J., Coleman C., Anrather J., Milner T., et al. Central cardiovascular circuits contribute to the neurovascular dysfunction in angiotensin II hypertension. J Neurosci 2012, 32(14):4878-4886.
25. Eysenck M.W., Derakshan N., Santos R., Calvo M.G. Anxiety and cognitive performance: attentional control theory. Emotion 2007, 7(2):336-353.
26. Ferguson S.A., Cada A.M. Spatial learning/memory and social and nonsocial behaviors in the spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rat strains. Pharmacol Biochem Behav 2004, 77(3):583-594.
27. Calzavara M.B., Lopez G.B., Abílio V.C., Silva R.H., Frussa-Filho R. Role of anxiety levels in memory performance of spontaneously hypertensive rats. Behav Pharmacol 2004, 15(8):545-553.
28. Ohl Frauke, Roedel Angelika, Binder Elke, Holsboer Florian Impact of high and low anxiety on cognitive performance in a modified hole board test in C57BL/6 and DBA/2 mice. Eur J Neurosci 2003, 17:128-136.
29. Silva R.H., Frussa-Filho R. The plus-maze discriminative avoidance task: a new model to study memory-anxiety interactions. Effects of chlordiazepoxide and caffeine. J Neurosci Methods 2000, 102(2):117-125.
30. Reed T.T. Lipid peroxidation and neurodegenerative disease. Free Radic Biol Med 2011, 51:1302-1319.
31. Salim S., Asghar M., Chugh G., Taneja M., Xia Z., Saha K. Oxidative stress: a potential recipe for anxiety, hypertension and insulin resistance. Brain Res 2010, 1359:178-185.
32. Raz L., Zhang Q.G., Zhou C.F., Han D., Gulati P., Yang L.C., et al. Role of Rac1 GTPase in NADPH oxidase activation and cognitive impairment following cerebral ischemia in the rat. PLoS One 2010, 5(9):e12606.
33. Pinnen F., Sozio P., Cacciatore I., Cornacchia C., Mollica A., Iannitelli A., et al. Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease. Arch Pharm 2010, 344(3):139-148.
34. Shichiri M., Yoshida Y., Ishida N., Hagihara Y., Iwahashi H., Tamai H., et al. α-Tocopherol suppresses lipid peroxidation and behavioral and cognitive impairments in the Ts65Dn mouse model of Down syndrome. Free Radic Biol Med 2011, 50(12):1801-1811.
35. Washida K., Ihara M., Nishio K., Fujita Y., Maki T., Yamada M., et al. Nonhypotensive dose of telmisartan attenuates cognitive impairment partially due to peroxisome proliferator-activated receptor-gamma activation in mice with chronic cerebral hypoperfusion. Stroke 2010, 41(8):1798-1806.
36. Pelisch N., Hosomi N., Ueno M., Nakano D., Hitomi H., Mogi M., et al. Blockade of AT1 receptors protects the blood-brain barrier and improves cognition in Dahl salt-sensitive hypertensive rats. Am J Hypertens 2011, 24(3):362-368.
37. Hirawa N., Uehara Y., Kawabata Y., Numabe A., Gomi T., Ikeda T., et al. Long-term inhibition of renin-angiotensin system sustains memory function in aged Dahl rats. Hypertension 1999, 34(3):496-502.